ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.

Michael J Grant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.